ANI Pharmaceuticals Inc (NASDAQ:ANIP)
| 41.87 Delayed Data As of 3:59pm ET |  +1.83 / +4.57%Today’s Change | 26.10 Today|||52-Week Range 60.23 | +44.18% Year-to-Date |
Latest ANIP News | Press Releases
No recent news for ANI Pharmaceuticals Inc.
Today’s Trading
| Previous close | 40.04 |
| Today’s open | 40.76 |
| Day’s range | 40.34 - 42.42 |
| Volume | 5,043 |
| Average volume (3 months) | 156,290 |
| Market cap | $524.5M |
Data as of 3:59pm ET, 12/07/2021
Growth & Valuation
| Earnings growth (last year) | -472.08% |
| Earnings growth (this year) | -0.67% |
| Earnings growth (next 5 years) | +17.70% |
| Revenue growth (last year) | +0.93% |
| P/E ratio | NM |
| Price/Sales | 1.67 |
| Price/Book | 2.60 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DTILPrecision BioScience... | +0.60 | +7.26% |
| SIGASIGA Technologies In... | +0.57 | +7.77% |
| DCPHDeciphera Pharmaceut... | +0.25 | +3.11% |
| RYTMRhythm Pharmaceutica... | +0.58 | +6.32% |
Data as of 4:00pm ET, 12/07/2021
Financials
| Next reporting date | March 3, 2022 |
| EPS forecast (this quarter) | $0.75 |
| Annual revenue (last year) | $208.5M |
| Annual profit (last year) | -$22.5M |
| Net profit margin | -10.82% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Baudette, Minnesota |
Forecasts
